Are Analysts Bullish GlaxoSmithKline plc (LON:GSK) After Last Week?

October 13, 2017 - By wolcottdaily

 Are Analysts Bullish GlaxoSmithKline plc (LON:GSK) After Last Week?

GlaxoSmithKline plc (LON:GSK) Ratings Coverage

Among 28 analysts covering GlaxoSmithKline PLC (LON:GSK), 8 have Buy rating, 4 Sell and 16 Hold. Therefore 29% are positive. GlaxoSmithKline PLC had 391 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Monday, June 27 by Deutsche Bank. The firm has “Hold” rating by Shore Capital given on Wednesday, January 11. The company was maintained on Friday, July 29 by BNP Paribas. The stock of GlaxoSmithKline plc (LON:GSK) has “Equalwt/In-Line” rating given on Friday, October 2 by Morgan Stanley. The firm has “Hold” rating by Shore Capital given on Thursday, March 30. The company was maintained on Thursday, March 31 by JP Morgan. The firm earned “Hold” rating on Thursday, September 10 by Deutsche Bank. Credit Suisse maintained GlaxoSmithKline plc (LON:GSK) on Friday, October 21 with “Neutral” rating. The firm has “Hold” rating by Jefferies given on Friday, April 15. Liberum Capital maintained GlaxoSmithKline plc (LON:GSK) on Wednesday, August 30 with “Buy” rating. Below is a list of GlaxoSmithKline plc (LON:GSK) latest ratings and price target changes.

11/10/2017 Broker: Deutsche Bank Rating: Hold Old Target: GBX 1610.00 New Target: GBX 1610.00 Maintain
04/10/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 1900.00 New Target: GBX 1760.00 Maintain
02/10/2017 Broker: JP Morgan Rating: Neutral Old Target: GBX 1570.00 New Target: GBX 1570.00 Maintain
21/09/2017 Broker: JP Morgan Rating: Neutral Maintain
20/09/2017 Broker: Deutsche Bank Rating: Hold Old Target: GBX 1610.00 New Target: GBX 1610.00 Maintain
19/09/2017 Broker: Berenberg Rating: Buy Old Target: GBX 1835.00 New Target: GBX 1835.00 Maintain
18/09/2017 Broker: Jefferies Rating: Buy Old Target: GBX 1750.00 New Target: GBX 1675.00 Reiteration
19/09/2017 Broker: Bryan Garnier & Cie Rating: Neutral Old Target: GBX 1710.00 New Target: GBX 1710.00 Maintain
19/09/2017 Broker: Shore Capital Rating: Hold Maintain
14/09/2017 Broker: Shore Capital Rating: Hold Maintain

The stock decreased 0.66% or GBX 10.04 on October 13, reaching GBX 1517.46. About 5.53 million shares traded. GlaxoSmithKline plc (LON:GSK) has 0.00% since October 13, 2016 and is . It has underperformed by 16.70% the S&P500.

GlaxoSmithKline plc is a global healthcare company. The company has market cap of 74.64 billion GBP. The Firm operates through three divisions: Pharmaceuticals, Vaccines and Consumer Healthcare. It has a 38.47 P/E ratio. The Firm focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus /infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.

More recent GlaxoSmithKline plc (LON:GSK) news were published by: Streetinsider.com which released: “Innoviva (INVA) & GlaxoSmithKline Plc (GSK) Granted Approval by FDA for Once …” on September 19, 2017. Also Bloomberg.com published the news titled: “Glaxo Finds a Rich Vein to Mine With Supercomputers” on October 13, 2017. Nasdaq.com‘s news article titled: “Is GlaxoSmithKline plc (GSK) a Suitable Value Stock?” with publication date: September 20, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.